Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 10
Submit an article Journal homepage
170
Views
0
CrossRef citations to date
0
Altmetric
Technology Review

Modeling Approaches for Ligand-Based 3D Similarity

Gary Tresadern1 Johnson & Johnson Pharmaceutical Research & Development, Janssen-Cilag S A, Calle Jarama 75, Poligono Industrial, 45007Toledo, SpainCorrespondence[email protected]
View further author information
&
Daniele Bemporad2 Johnson & Johnson Pharmaceutical Research & Development, Janssen Pharmaceutical N.V., Turnhoutseweg 30, 2340Beerse, BelgiumView further author information
Pages 1547-1561 | Published online: 13 Oct 2010

Bibliography

  • Reddy A , PatiS, KumarP, PradeepH, SastryG. Virtual screening in drug discovery – a computational perspective.Curr. Protein Peptide Sci.8, 329–351 (2007).
  • Good A . Virtual screening.Comp. Med. Chem. II.4, 459–494 (2006).
  • Hristozov D , OpreaT, GasteigerJ. Virtual screening applications; a study of ligand based methods and different structure representations in four different scenarios.J. Comput. Aided Mol. Des.21, 617–640 (2007).
  • Irwin JJ , ShoichetBK. ZINC – a free database of commercially available compounds for virtual screening.J. Chem. Inf. Model.45, 177–182 (2005).
  • Chuprina A , LukinO, DemoiseauxR, BuzkoA, ShivanyukA. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.J. Chem. Inf. Model.50, 470–479 (2010).
  • Martin YC , KofronJL, TraphagenLM. Do structurally similar molecules have similar biological activity?J. Med. Chem.45, 4350–4358 (2002).
  • Leach AR , GilletVJ, LewisRA, TaylorR. Three-dimensional pharmacophore methods in drug discovery.J. Med. Chem.53, 539–558 (2010).
  • Kortagere S , KrasowskiMD, EkinsS. The importance of discerning shape in molecular pharmacology.Trends in Pharma. Sci.30, 138–147 (2009).
  • Nicholls A , McGaugheyGB, SheridanRPet al. Molecular shape and medicinal chemistry: a perspective. J. Med. Chem. 53, 3862–3886 (2010).
  • Hopfinger AJ . A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis.J. Am. Chem. Soc.102, 7196–7206 (1980).
  • Goodford PJ . A computational procedure for determining energetically favorable binding sites on important marcomolecules.J. Med. Chem.28, 849–857 (1985).
  • Cramer RD , PattersonDE, BunceJD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.J. Am. Chem. Soc.110, 5959–5967 (1988).
  • Cross S , CrucianiG. Molecular fields in drug discovery: getting old or reaching maturity?Drug Discov. Today15, 23–32 (2010).
  • Shoichet BK . Virtual screening of chemical libraries.Nature432, 862–865 (2004).
  • Tresadern G , BemporadD, HoweT. A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor.J. Mol. Graph. Model.27, 860–870 (2009).
  • Tresadern G , AgrafiotisDK. Conformational sampling with stochastic proximity embedding and self-organizing superimposition: establishing reasonable parameters for their practical use.J. Chem. Inf. Model.49, 2786–2800 (2009).
  • Cummings MD , GibbsAC, DesJarlaisRL. Processing of small molecule databases for automated docking.Med. Chem.3, 107–113 (2007).
  • Knox AJ , MeeganMJ, CartaG, LloydDG. Considerations in compound database preparation – ‘hidden’ impact on virtual screening results.J. Chem. Inf. Model.45, 1908–1919 (2005).
  • Griewel A , KayserO, SchlosserJ, RareyM. Conformational sampling for large-scale virtual screening: accuracy versus ensemble size.J. Chem. Inf. Model.49, 2303–2311 (2009).
  • Yogendra P , GilletV, HoweT, PastorJ, OyarzabalJ, WillettP. Assessment of additive/nonadditive effects in structure–activity relationships for iterative drug design.J. Med. Chem.51, 7552–7562 (2008).
  • Tresadern G , CidJM, MacdonaldGJet al. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. Bioorg. Med. Chem. Lett. 20, 175–179 (2010).
  • Oyarzabal J , HoweT, AlcazarJet al. Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonists. J. Med. Chem. 52, 2076–2089 (2009).
  • Langdon SR , ErtlP, BrownN. Bioisosteric replacement and scaffold hopping in lead generation and optimization.Mol. Inf.29, 366–385 (2010).
  • Schneider G . Virtual screening: an endless staircase?Nature Rev. Drug Discov.9, 273–276 (2010).
  • Brown RD , MartinYC. Use of structure–activity data to compare structure-based clustering methods and descriptors for use in compound selection.J. Chem. Inf. Comput. Sci.36, 572–584 (1996).
  • Matter H , PötterT. Comparing 3D pharmacophore triplets and 2D fingerprints for selecting diverse compound subsets.J. Chem. Inf. Comput. Sci.39, 1211–1225 (1999).
  • Schuffenhauer A , GilletVJ, WillettP. Similarity searching in files of three-dimensional chemical structures: analysis of the BIOSTER database using two-dimensional fingerprints and molecular field descriptors.J. Chem. Inf. Comput. Sci.40, 295–307 (2000).
  • Sheridan RP , KearsleySK. Why do we need so many chemical similarity search methods?Drug Discov. Today7, 903–911 (2002).
  • Schneider G , SchneiderP, RennerS. Scaffold-hopping: how far can you jump?QSAR Combin. Sci.25, 1162–1171 (2006).
  • Mackey MD , MelvilleJL. Better than random? The chemotype enrichment problem.J. Chem. Inf. Model.49, 1154–1162 (2009).
  • Vogt M , StumpfeD, GeppertH, BajorathJ. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening.J. Med. Chem.53, 5707–5715 (2010).
  • Hawkins PCD , SkillmanAG, NichollsA. Comparison of shape-matching and docking as virtual screening tools.J. Med. Chem.50, 74–82 (2007).
  • Güner OF . History and evolution of the pharmacophore concept in computer-aided drug design.Curr. Top. Med. Chem.2, 1321–1332 (2002).
  • Grant JA , GallardoMA, PickupBT. A fast method of molecular shape comparison: a simple application of gaussian description of molecular shape.J. Comp. Chem.17, 1653–1666 (1996).
  • Rush TS , GrantJA, MosyakL, NichollsA. A shape-based 3D scaffold hopping method and its application to a bacterial protein–protein interaction.J. Med. Chem.48, 1489–1495 (2005).
  • Fan Y , LaiMH, SullivanKet al. The identification of neurotensin NTS1 receptor partial agonists through a ligand based virtual screening approach. Bioorg. Med. Chem. Lett. 18, 5789–5791 (2008).
  • Perruccio F , MasonJS, SciabolaS, BaroniM. FLAP: 4-Point Pharmacophore Fingerprints From GRID. GRID-Based Molecular Interaction Field in Cheminoformatics and Drug Design. Cruciani G (Ed). Wiley-VCH, Weinheim, Germany, 83–102 (2005).
  • Baroni M , CrucianiG, SciabolaS, PerruccioF, MasonJS. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application.J. Chem. Inf. Model.47, 279–294 (2007).
  • Carosati E , CrucianiG, ChiariniAet al. Calcium channel antagonists discovered by a multidisciplinary approach. J. Med. Chem. 49, 5206–5216 (2006).
  • Cramer RD , JilekRJ, AndrewsKM. Dbtop: topomer similarity searching of conventional structure databases.J. Mol. Graph. Model.20, 447–462 (2002).
  • Jilek RJ , CramerRD. Topomers: a validated protocol for their self-consistent generation.J. Chem. Inf. Comput. Sci.44, 1221–1227.
  • Chiu TL , SolbergJ, PatilSet al. Identification of novel nonhydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening. J. Chem. Inf. Model. 49, 2726–2734 (2009).
  • Vinter JG , TrollopeKI. Multiconformational composite molecular-potential fields in the analysis of drug-action. 1. methodology and first evaluation using 5-HT and histamine action as examples.J. Comput. Aided Mol. Des.9, 297–307 (1995).
  • Cheeseright T , MackeyM, RoseS, VinterA. Molecular field extrema as descriptors of biological activity: definition and validation.J. Chem. Inf. Model.46, 665–676 (2006).
  • Cheeseright TJ , MackeyMD, MelvilleJL, VinterJG. Fieldscreen: virtual screening using molecular fields. Application to the DUD data set.J. Chem. Inf. Model.48, 2108–2117 (2008).
  • Cheeseright TJ , HolmM, LehmannFet al. Novel lead structures for p38 MAP kinase via fieldscreen virtual screening. J. Med. Chem. 52, 4200–4209 (2009).
  • Bellenie BR , BartonNP, EmmonsAJ, HeerJP, SalvagnoC. Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design.Bioorg. Med. Chem. Lett.19, 990–994 (2009).
  • Hurst TJ . Flexible 3D searching: the directed tweak technique.J. Chem. Inf. Comput. Sci.34, 190–196 (1994).
  • Sprague PW . De Novo Design. Muller K (Ed.). Leiden: ESCOM Science Publishers, Leiden, The Netherlands, 1–20 (1995).
  • Khedkar SA , AlpeshkumarKM, CountinhoEC, SrivastavaS. Pharmacophore modeling in drug discovery and development: an overview.Med. Chem.3, 187–197 (2007).
  • Foloppe N , BenwellK, BrooksTDet al. Discovery and functional evaluation of diverse novel human CB1 receptor ligands. Bioorg. Med. Chem. Lett. 19, 4183–4190 (2009).
  • Nicholls A , MacCuishNE, MacCuishJD. Variable selection and model validation of 2D and 3D molecular descriptors.J. Comput. Aided Mol. Des.18, 451–474 (2004).
  • Bergmann R , LiljeforsT, SorensenMD, ZamoraI. SHOP: receptor-based scaffold hopping by GRID-based similarity searches.J. Chem. Inf. Model.49, 658–669 (2009).
  • Fontaine F , CrossS, PlasenciaG, PastorM, ZamoraI. SHOP: a method for structure-based fragment and scaffold hopping.ChemMedChem.4, 427–439 (2009).
  • Bergmann R , LinussonA, ZamoraI. SHOP: scaffold hopping by GRID-based similarity searches.J. Med. Chem.50, 2708–2717 (2007).
  • Ahlström MM , RidderströmM, LuthmanK, ZamoraI. Virtual screening and scaffold hopping based on GRID molecular interaction fields.J. Chem. Inf. Model.45, 1313–1323 (2005).
  • Maass P , Schulz-GaschT, StahlM, RareyM. Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations.J. Chem. Inf. Model.47, 390–399 (2007).
  • Pastor M , CrucianiG, McLayI, PickettS, ClementiS. Grid independent descriptors (GRIND). A novel class of alignment-independent three-dimensional molecular descriptors.J. Med. Chem.43, 3233–3243 (2000).
  • Fontaine F , PastorM, SanzF. Incorporating molecular shape into the alignment-free grid-independent descriptors.J. Med. Chem.47, 2805–2815 (2004).
  • Duran A , ZamoraI, PastorM. Suitability of GRIND-based principal properties for the description of molecular similarity and ligand based virtual screening.J. Chem. Inf. Model.49, 2129–2138 (2009).
  • Fontaine F , PastorM, ZamoraI, SanzF. Filling the gap between standard 3D QSAR and the grind-independent descriptors.J. Med. Chem.48, 2687–2694 (2005).
  • Cramer RD . Topomer CoMFA: a design methodology for rapid lead optimization.J. Med. Chem.46, 374–388 (2003).
  • Cramer RD , CruzP, StahlGet al. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using topomer CoMFA. J. Chem. Inf. Model. 48, 2180–2195 (2008).
  • Sheridan RP , KearsleySK. Why do we need so many chemical similarity search methods?Drug Discov. Today7, 903–911 (2002).
  • Willett P . Enhancing the effectiveness of ligand based virtual screening using data fusion.QSAR Combin. Sci.25, 1143–1152 (2006).
  • Tan L , GeppertH, SisayMT, GutschowM, BajorathJ. Integrating structure and ligand based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets.ChemMedChem.3, 1566–1571 (2008).
  • Chen J , HollidayJ, BradshawJ. A machine learning approach to weighting schemes in the data fusion of similarity coefficients.J. Chem. Inf. Model.49, 185–194 (2009).
  • Muchmore SW , DebeDA, MetzJT, BrownSP, MartinYC, HajdukPJ. Application of belief theory to similarity data fusion for use in analog searching and lead hopping.J. Chem. Inf. Model.48, 941–948 (2008).
  • Truchon JF , NichollsA, RouxB, IftimieRI, BaylyCI. Integrated continuum dielectric approaches to treat molecular polarizability and the condensed phase: refractive index and implicit solvation.J. Chem. Theory Comput.5, 1785–1802 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.